Clin2
NCT07690228Likely a fitNot yet recruiting

Study of a new medicine in healthy adults

Healthy Adult ParticipantsAlzheimer Disease

Part of Brain & nervous system, Mental health clinical trials.

This early-stage trial tests a new medicine called GSM-779690T in healthy volunteers to see how safe it is and how the body handles it. Participating could help determine if the medicine is worth testing in people with certain conditions later.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
72 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are in good overall health, with no major medical conditions.
  • You score between 27 and 30 on a short memory and thinking test.
  • You can read, speak, and understand English.
  • You are willing to stay at the clinic for the study and follow birth control rules if needed.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06995573Recruiting· Phase 1/Phase 2
Testing a new Alzheimer's drug (NSC001) for safety and early effectiveness

This study tests a new drug called NSC001 for people with mild to moderate Alzheimer's. It checks if the drug is safe and if it might help slow memory decline. You'll need a caregiver who can join you at visits and help track your progress.

Salzburg, State of Salzburg
NCT07143331Not yet recruiting· Phase 1
Testing a new medicine for safety in healthy volunteers

This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.

Sydney, New South Wales
NCT06885567Not yet recruiting· Phase 2
Testing a new drug for early Alzheimer's disease

This study tests an investigational drug called BEY2153 for people with early Alzheimer's disease. It aims to see if the drug is safe and can help slow memory decline.

Seoul
NCT06657768Recruiting· Phase 1
Study of LY4006895 for healthy people and those with early Alzheimer's

This trial tests a new medicine called LY4006895 in two groups: healthy volunteers and people with early symptomatic Alzheimer's disease. It aims to see how the drug works in the body and if it might help memory and thinking.

Los Alamitos, California
NCT06535308Recruiting· Phase 1
Testing a new Alzheimer's drug for moderate disease

This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.

Seoul, Jongno-gu
NCT07660341Recruiting· Phase 1
Study of CGB3002 in healthy volunteers

This trial tests a new drug, CGB3002, to see how safe it is and how the body processes it. Healthy volunteers are needed to help determine the right dose and check for side effects.

Melbourne, Victoria

Hear when a new Healthy Adult Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.